Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system
Open accessThe DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
Background: Cancer treatment with a variety of chemotherapeutic agents often is associated with delayed adverse neurological consequences. Despite their clinical importance, almost nothing is known about the basis for such effects. It is not even known whether the occurrence of delayed adverse effects requires exposure to multiple chemotherapeutic agents, the presence of both chemotherapeutic agents and the body's own response to cancer, prolonged damage to the blood-brain barrier, inflammation or other such changes. Nor are there any animal models that could enable the study of this important problem. Results: We found that clinically relevant concentrations of 5-fluorouracil (5-FU; a widely used chemotherapeutic agent) were toxic for both central nervous system (CNS) progenitor cells and non-dividing oligodendrocytes in vitro and in vivo. Short-term systemic administration of 5-FU caused both acute CNS damage and a syndrome of progressively worsening delayed damage to myelinated tracts of the CNS associated with altered transcriptional regulation in oligodendrocytes and extensive myelin pathology. Functional analysis also provided the first demonstration of delayed effects of chemotherapy on the latency of impulse conduction in the auditory system, offering the possibility of non-invasive analysis of myelin damage associated with cancer treatment. Conclusions: Our studies demonstrate that systemic treatment with a single chemotherapeutic agent, 5-FU, is sufficient to cause a syndrome of delayed CNS damage and provide the first animal model of delayed damage to white-matter tracts of individuals treated with systemic chemotherapy. Unlike that caused by local irradiation, the degeneration caused by 5-FU treatment did not correlate with either chronic inflammation or extensive vascular damage and appears to represent a new class of delayed degenerative damage in the CNS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 CNS progenitor cells are vulnerable to clinically relevant levels of 5-FU exposure. (a) A summary of the putative relationships between the different cell types under study (for discussion of this and alternative views on lineage relationships in the CNS, see [199,200]). Pluripotent neuroepithelial stem cells (NSC) give rise to glial restricted precursor (GRP) cells and neuron restricted precursor (NRP) cells. GRP cells in turn give rise to astrocytes and oligodendrocyte-type-2 astrocyte progenitor/oligodendrocyte precursor cells (O-2A/OPCs), the ancestors of oligodendrocytes. (b,c) Primary CNS cells (b) or various cancer cell lines (c) were grown on coverslips and exposed to 5-FU for 24 h before analysis of cell viability as described in Materials and methods. 5-FU concentrations were chosen on the basis of drug concentrations reached in humans after conventional 5-FU treatment. None of the tumor lines tested were sensitive to 5-FU treatment in this dose range, whereas O-2A/OPCs, oligodendrocytes, GRP cells and human umbilical vein endothelial cells (HUVECs) were sensitive. (d,e) Exposure conditions designed to mimic the exposure levels associated with long-term infusion (d) or high-dose bolus administration (e) yielded similar results, with vulnerability of O-2A/OPCs and non-dividing oligodendrocytes to 5-FU exceeding the vulnerability of rapidly dividing cancer cells. As shown in (b,d), the vulnerability of HUVECs also exceeds the vulnerability of cancer cells. Each experiment was carried out in quadruplicate and was repeated at least twice in independent experiments. Data represent mean of survival ± s.e.m, normalized to control values.](https://figures.cochat.ai/paper-figures/1e1e4baf61204ebcbcfb8ba9503ec507/systemic-5-fluorouracil-treatment-causes-a-syndrome-of-delayed-myelin-figure-1.jpg)










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mainstay of CRC treatment, 5‐fluorouracil, has several side effects, including toxicity to both central nervous system progenitor cells and oligodendrocytes, even in the short term, limiting its long‐term clinical use [31, 32].”
From Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models (2024) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain
Doetsch, F., Caillé, I., Lim, D. A., García-Verdugo, J. M., & Alvarez-Buylla, A. (1999) · Cell · doi:10.1016/s0092-8674(00)80783-7 · Cited by 3,898 · cited 20×
“In the SVZ, 5-FU exposure was associated with a 40.9 ± 2.6% decrease in numbers of BrdU+ cells on day 1, with a transient re-population of BrdU+ cells at days 7 and 14, followed by a subsequent decrease in animals examined at day 56 and 6 months after completion of treatment.”
BackgroundMethodInfluentialInflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Raff, M. C., Miller, R. H., & Noble, M. (1983) · Nature · doi:10.1038/303390a0 · Cited by 2,030
Self-citationF4/80, a monoclonal antibody directed specifically against the mouse macrophage
Austyn, J. M., & Gordon, S. (1981) · European Journal of Immunology · doi:10.1002/eji.1830111013 · Cited by 1,579
Transient expression of doublecortin during adult neurogenesis
Brown, J. P., Couillard‐Després, S., Cooper‐Kuhn, C. M., Winkler, J., Aigner, L., & Kuhn, H. G. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10874 · Cited by 1,496
Neurogenesis in Adult Subventricular Zone
Alvarez-Buylla, A., & Garcı́a-Verdugo, J. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00629.2002 · Cited by 1,466
Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H., & Skipper, H. E. (1966) · PubMed · Cited by 1,382
Irradiation induces neural precursor-cell dysfunction
Monje, M. L., Mizumatsu, S., Fike, J. R., & Palmer, T. D. (2002) · Nature Medicine · doi:10.1038/nm749 · Cited by 1,271
Clinical Pharmacology of 5-Fluorouracil
Diasio, R. B., & Harris, B. E. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916040-00002 · Cited by 969
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968
Report of two cases and review of the literature
Ekovic, G. P. L., Mariwalla, N. R., Horn, E. M., Chang, S. W., Rekate, H. L., & Theodore, N. (2006) · Cited by 865
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
van Dam, F. S. A. M., Boogerd, W., Schagen, S. B., Muller, M. J., Droogleever Fortuyn, M. E., Wall, E. V. D., & Rodenhuis, S. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.210 · Cited by 763
Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.485 · Cited by 736
Cisplatin and platinum drugs at the molecular level (Review)
Boulikas, T., & Vougiouka, M. (2003) · Oncology Reports · doi:10.3892/or.10.6.1663 · Cited by 729
Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20272 · Cited by 679
Head, D. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh003 · Cited by 645
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
Schagen, S. B., van Dam, F. S. A. M., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<640::aid-cncr14>3.0.co;2-g · Cited by 620
Packer, R. J., Goldwein, J., Nicholson, H. S., Vezina, L. G., Allen, J. C., Ris, M. D., Muraszko, K., Rorke, L. B., Wara, W. M., Cohen, B. H., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2127 · Cited by 617
Marked loss of myelinated nerve fibers in the human brain with age
Marner, L., Nyengaard, J. R., Tang, Y., & Pakkenberg, B. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10714 · Cited by 599
The effects of normal aging on myelin and nerve fibers: a review
Peters, A. (2002) · Journal of Neurocytology · doi:10.1023/a:1025731309829 · Cited by 577
Bjartmar, C., Wujek, J. R., & Trapp, B. D. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00069-2 · Cited by 573
Mechanisms of cisplatin-induced ototoxicity and prevention
Rybak, L. P., Whitworth, C. A., Mukherjea, D., & Ramkumar, V. (2007) · Hearing Research · doi:10.1016/j.heares.2006.09.015 · Cited by 563
Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Brezden, C. B., Phillips, K.-A., Abdolell, M., Bunston, T., & Tannock, I. F. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2695 · Cited by 557
The Radioresponse of the Central Nervous System: A Dynamic Process
Tofilon, P. J., & Fike, J. R. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)153[0357:trotcn]2.0.co;2 · Cited by 526
Dietrich, J., Han, R., Yang, Y., Mayer-Pröschel, M., & Noble, M. (2006) · Journal of Biology · doi:10.1186/jbiol50 · Cited by 500
Self-citationThe central nervous system in childhood leukemia.II. Subacute leukoencephalopathy
Price, R. A., & Jamieson, P. A. (1975) · Cancer · doi:10.1002/1097-0142(197502)35:2<306::aid-cncr2820350203>3.0.co;2-j · Cited by 479
Medulloblastoma in childhood. Survival and functional results
Hirsch, J. F., Renier, D., Czernichow, P., Benveniste, L., & Pierre-Kahn, A. (1979) · Acta Neurochirurgica · doi:10.1007/bf01406016 · Cited by 467
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
Sultana, A., Smith, C. T., Cunningham, D., Starling, N., Neoptolemos, J. P., & Ghaneh, P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2551 · Cited by 442
Bartzokis, G., Cummings, J. L., Sultzer, D., Henderson, V. W., Nuechterlein, K. H., & Mintz, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.393 · Cited by 413
Jenkins, V, Shilling, V, Deutsch, G., Bloomfield, D., Morris, R., Allan, S., Bishop, H., Hodson, N., Mitra, S., Sadler, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603029 · Cited by 407
Smith, J., Ladi, E., Mayer-Pröschel, M., & Noble, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170209797 · Cited by 399
Self-citationSilverman, D. H. S., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., Waddell, K., Petersen, L., Phelps, M. E., & Ganz, P. A. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9380-z · Cited by 397
Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen
Castellon, S. A., Ganz, P. A., Bower, J. E., Petersen, L., Abraham, L., & Greendale, G. A. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490510905 · Cited by 396
Axon pathology in neurological disease: a neglected therapeutic target
Coleman, M. P., & Perry, V. H. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02255-5 · Cited by 389
Iron Deficiency Anemia in Infancy: Long-Lasting Effects on Auditory and Visual System Functioning
Algarín, C., Peirano, P., Garrido, M., Pizarro, F., & Lozoff, B. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000047657.23156.55 · Cited by 375
Roncagliolo, M., Garrido, M., Walter, T., Peirano, P., & Lozoff, B. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.3.683 · Cited by 371
Madden, D. J., Whiting, W. L., Huettel, S. A., White, L. E., MacFall, J. R., & Provenzale, J. M. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.11.004 · Cited by 369
Isolation of Lineage-Restricted Neuronal Precursors from Multipotent Neuroepithelial Stem Cells
Mayer-Proschel, M., Kalyani, A. J., Mujtaba, T., & Rao, M. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80960-5 · Cited by 369
Self-citationPacker, R. J., Sutton, L. N., Atkins, T. E., Radcliffe, J., Bunin, G. R., D'Angio, G., Siegel, K. R., & Schut, L. (1989) · Journal of Neurosurgery · doi:10.3171/jns.1989.70.5.0707 · Cited by 351
Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., Wada, N., Imoto, S., Murakami, K., Uchitomi, Y., et al. (2007) · Cancer · doi:10.1002/cncr.22368 · Cited by 350
Cognitive impairment associated with adjuvant therapy in breast cancer
Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., & Ryan, C. M. (2006) · Psycho-Oncology · doi:10.1002/pon.964 · Cited by 320
Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K.-A. (2005) · Brain and Cognition · doi:10.1016/j.bandc.2005.05.001 · Cited by 315
A tripotential glial precursor cell is present in the developing spinal cord
Rao, M. S., Noble, M., & Mayer-Pröschel, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3996 · Cited by 310
Self-citationMulhern, R. K., Palmer, S. L., Reddick, W. E., Glass, J. O., Kun, L. E., Taylor, J., Langston, J., & Gajjar, A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.472 · Cited by 307
Fancy, S. P. J., Zhao, C., & Franklin, R. J. M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.06.015 · Cited by 302
Brück, W. (2005) · Journal of Neurology · doi:10.1007/s00415-005-5002-7 · Cited by 300
Di Bartolomeo, M., Bajetta, E., Buzzoni, R., Mariani, L., Carnaghi, C., Somma, L., Zilembo, N., Di Leo, A., & ITMO Association (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2<402::aid-cncr25>3.0.co;2-4 · Cited by 296
Schagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., & van Dam, F. S. A. M. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj470 · Cited by 295
Peylan-Ramu, N., Poplack, D. G., Pizzo, P. A., Adornato, B. T., & Di Chiro, G. (1978) · New England Journal of Medicine · doi:10.1056/nejm197804132981504 · Cited by 294
Age‐Related Changes in Prefrontal White Matter Measured by Diffusion Tensor Imaging
SALAT, D. H., TUCH, D. S., HEVELONE, N. D., FISCHL, B., CORKIN, S., ROSAS, H. D., & DALE, A. M. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1340.009 · Cited by 292
Delayed Neurotoxicity in Primary Central Nervous System Lymphoma
Omuro, A. M. P., Ben-Porat, L. S., Panageas, K. S., Kim, A. K., Correa, D. D., Yahalom, J., DeAngelis, L. M., & Abrey, L. E. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1595 · Cited by 286
Glial-Restricted Precursors Are Derived from Multipotent Neuroepithelial Stem Cells
Rao, M. S., & Mayer-Proschel, M. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8597 · Cited by 284
Self-citationFan, H. G. M., Houédé-Tchen, N., Yi, Q.-L., Chemerynsky, I., Downie, F. P., Sabate, K., & Tannock, I. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6550 · Cited by 280
Aging and the myelinated fibers in prefrontal cortex and corpus callosum of the monkey
Peters, A., & Sethares, C. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10099 · Cited by 273
Krishnan, S., Rana, V., Janjan, N. A., Varadhachary, G. R., Abbruzzese, J. L., Das, P., Delclos, M. E., Gould, M. S., Evans, D. B., Wolff, R. A., et al. (2007) · Cancer · doi:10.1002/cncr.22735 · Cited by 272
Multipotent and restricted precursors in the central nervous system
Rao, M. S. (1999) · The Anatomical Record · doi:10.1002/(sici)1097-0185(19990815)257:4<137::aid-ar7>3.0.co;2-q · Cited by 268
Hurria, A., Rosen, C., Hudis, C., Zuckerman, E., Panageas, K. S., Lachs, M. S., Witmer, M., Van Gorp, W. G., Fornier, M., D'Andrea, G., et al. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00732.x · Cited by 264
Age‐Related White Matter Atrophy in the Human Brain
MEIER‐RUGE, W., ULRICH, J., BRÜHLMANN, M., & MEIER, E. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb27462.x · Cited by 256
Neurological complications of radiotherapy and chemotherapy
Keime-Guibert, F., Napolitano, M., & Delattre, J.-Y. (1998) · Journal of Neurology · doi:10.1007/s004150050271 · Cited by 246 · cited 2×
“Adverse neurological effects have been observed with almost all categories of chemotherapeutic agents [19-22], including antimetabolites (such as cytosine arabinoside (Ara-C) [23], 5-fluorouracil (5-FU) [24,25], methotrexate [26-28], DNA cross-linking agents (such as BCNU [29] and cisplatin [30]) and even anti-hormona…”
BackgroundDuffner, P. K. (2004) · The Neurologist · doi:10.1097/01.nrl.0000144287.35993.96 · Cited by 235
Preliminary Assessment of Cognitive Function in Breast Cancer Patients Treated with Tamoxifen
Paganini-Hill, A., & Clark, L. J. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006426132338 · Cited by 227
Jenkins, V., Shilling, V., Fallowfield, L., Howell, A., & Hutton, S. (2004) · Psycho-Oncology · doi:10.1002/pon.709 · Cited by 227
Johnson, M. R., Hageboutros, A., Wang, K., High, L. B., Smith, J. B., & Diasio, R. B. (1999) · PubMed · Cited by 225
Therasse, P., Mauriac, L., Welnicka-Jaskiewicz, M., Bruning, P., Cufer, T., Bonnefoi, H., Tomiak, E., Pritchard, K. I., Hamilton, A., & Piccart, M. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.135 · Cited by 224
Late effects of treatment on the intelligence of children with posterior fossa tumors
Duffner, P. K., Cohen, M. E., & Thomas, P. (1983) · Cancer · doi:10.1002/1097-0142(19830115)51:2<233::aid-cncr2820510211>3.0.co;2-8 · Cited by 216
Estrogen- and tamoxifen-associated effects on brain structure and function
Eberling, J. L., Wu, C., Tong-Turnbeaugh, R., & Jagust, W. J. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.08.037 · Cited by 213
Cognitive Effects of Standard-Dose Chemotherapy in Patients with Cancer
Ahles, T. A., & Saykin, A. (2001) · Cancer Investigation · doi:10.1081/cnv-100107743 · Cited by 213
Talbott, J. F., Loy, D. N., Liu, Y., Qiu, M. S., Bunge, M. B., Rao, M. S., & Whittemore, S. R. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.038 · Cited by 194
Martin, M., Villar, A., Sole-Calvo, A., Gonzalez, R., Massuti, B., Lizon, J., Camps, C., Carrato, A., Casado, A., Candel, M. T., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg260 · Cited by 188
An ‘oligarchy’ rules neural development
Rowitch, D. H., Lu, Q. R., Kessaris, N., & Richardson, W. D. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02201-4 · Cited by 181
Rowland, J. H., Glidewell, O. J., Sibley, R. F., Holland, J. C., Tull, R., Berman, A., Brecher, M. L., Harris, M., Glicksman, A. S., & Forman, E. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.12.1327 · Cited by 180
Neurocognitive dysfunction in cancer patients.
Meyers, C. A. (2000) · PubMed · Cited by 170
Application of Antioxidants and Other Agents to Prevent Cisplatin Ototoxicity
Rybak, L. P., Whitworth, C., & Somani, S. (1999) · The Laryngoscope · doi:10.1097/00005537-199911000-00003 · Cited by 169
Neurotoxicity secondary to antineoplastic drugs
Tuxen, M. K., & Hansen, S. W. (1994) · Cancer Treatment Reviews · doi:10.1016/0305-7372(94)90027-2 · Cited by 167
Wefel, J. S., Kayl, A. E., & Meyers, C. A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601772 · Cited by 167
Abraham, J., Haut, M. W., Morán, M. T. C., Filburn, S., Lemiuex, S., & Kuwabara, H. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.007 · Cited by 162
Cerebellar toxicity with high-dose cytosine arabinoside.
Herzig, R. H., Hines, J. D., Herzig, G. P., Wolff, S. N., Cassileth, P. A., Lazarus, H. M., Adelstein, D. J., Brown, R. A., Coccia, P. F., & Strandjord, S. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.6.927 · Cited by 162
First‐Time‐in‐Human Dose Selection: Allometric Thoughts and Perspectives
Boxenbaum, H., & DiLea, C. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04011.x · Cited by 161
The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study
Stewart, A., Collins, B., Mackenzie, J., Tomiak, E., Verma, S., & Bielajew, C. (2008) · Psycho-Oncology · doi:10.1002/pon.1210 · Cited by 154
Multifocal inflammatory leukoencephalopathy with 5‐fluorouracil and levamisole
Hook, C. C., Kimmel, D. W., Kvols, L. K., Scheithauer, B. W., Forsyth, P. A., Rubin, J., Moertel, C. G., & Rodriguez, M. (1992) · Annals of Neurology · doi:10.1002/ana.410310306 · Cited by 153
Fluorouracil-Induced Neurotoxicity
Pirzada, N. A., Ali, I., & Dafer, R. M. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.18425 · Cited by 142
Selection of adjuvant chemotherapy for treatment of node-positive breast cancer
Trudeau, M., Charbonneau, F., Gelmon, K. A., Laing, K. E., Latreille, J., Mackey, J. R., McLeod, D., Pritchard, K. I., Provencher, L., & Verma, S. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70424-1 · Cited by 136
The effects of hormone therapy on cognition in breast cancer
Shilling, V., Jenkins, V., Fallowfield, L., & Howell, T. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.07.001 · Cited by 135
Downie, F. P., Mar Fan, H. G., Houédé-Tchen, N., Yi, Q., & Tannock, I. F. (2006) · Psycho-Oncology · doi:10.1002/pon.1035 · Cited by 133
Adjuvant Breast Cancer Treatment and Cognitive Function: Current Knowledge and Research Directions
Phillips, K.-A., & Bernhard, J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.190 · Cited by 133
Schagen, S. B., Hamburger, H., Muller, M. J., Boogerd, W. J., & van Dam, F. S. A. M. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010635229762 · Cited by 132
Maison, S. F., Luebke, A. E., Liberman, M. C., & Zuo, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10838.2002 · Cited by 132
Self-citationTrimmer, E. E., & Essigmann, J. M. (1999) · Essays in Biochemistry · doi:10.1042/bse0340191 · Cited by 127
Roles of the mammalian subventricular zone in cell replacement after brain injury
Romanko, M. J., Rola, R., Fike, J. R., Szele, F. G., Dizon, M., Felling, R. J., Brazel, C. Y., & Levison, S. W. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.07.001 · Cited by 122
Brown, M. S., Stemmer, S. M., Simon, J. H., Stears, J. C., Jones, R. B., Cagnoni, P. J., & Sheeder, J. L. (1998) · PubMed Central · Cited by 118
Kitada, M., & Rowitch, D. H. (2006) · Glia · doi:10.1002/glia.20354 · Cited by 117
Medulloblastoma in childhood: comparative results of partial and total resection.
Raimondi, A. J., & Tomita, T. (1979) · PubMed · Cited by 117
Maturational time course for the ABR in preterm and full term infants
Eggermont, J. J., & Salamy, A. (1988) · Hearing Research · doi:10.1016/0378-5955(88)90019-6 · Cited by 116
Humes, H. D. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb00278.x · Cited by 116
Cognitive dysfunction and subjective complaints of cancer patients
Poppelreuter, M., Weis, J., Külz, A. K., Tucha, O. M., Lange, K. W., & Bartsch, H. H. (2003) · European Journal of Cancer · doi:10.1016/j.ejca.2003.08.001 · Cited by 113
Ibarrola, N., Mayer‐Pröschel, M., Rodríguez‐Peña, A., & Noble, M. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0280 · Cited by 110
Self-citationExtrapolation of animal toxicity to humans: Interspecies comparisons in drug development
Voisin, E., Ruthsatz, M., Collins, J. M., & Hoyle, P. C. (1990) · Regulatory Toxicology and Pharmacology · doi:10.1016/s0273-2300(05)80052-2 · Cited by 109
BOURKE, R. S., West, C. R., Chheda, G. B., & Tower, D. B. (1973) · PubMed · Cited by 107
Shimamura, M., Kobayashi, Y., Yuo, A., Urabe, A., Okabe, T., Komatsu, Y., Itoh, S., & Takaku, F. (1987) · Blood · doi:10.1182/blood.v69.1.353.353 · Cited by 105
Future opportunities in preventing cisplatin induced ototoxicity
van den Berg, J. H., Beijnen, J. H., Balm, A. J. M., & Schellens, J. H. M. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.04.011 · Cited by 101
Epigenetic memory loss in aging oligodendrocytes in the corpus callosum
Shen, S., Liu, A., Li, J., Wolubah, C., & Casaccia‐Bonnefil, P. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.026 · Cited by 99
What is the effect of systemic anticancer treatment on cognitive function?
Minisini, A. M., Atalay, G., Bottomley, A., Puglisi, F., Piccart, M. J., & Biganzoli, L. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01465-2 · Cited by 98
Getting a GR(i)P on oligodendrocyte development
Noble, M., Pröschel, C., & Mayer-Pröschel, M. (2003) · Developmental Biology · doi:10.1016/j.ydbio.2003.06.002 · Cited by 96
Self-citationOkeda, R., Shibutani, M., Matsuo, T., Kuroiwa, T., Shimokawa, R., & Tajima, T. (1990) · Acta Neuropathologica · doi:10.1007/bf00662639 · Cited by 96
Owens, T. (2003) · Current Opinion in Neurology · doi:10.1097/00019052-200306000-00003 · Cited by 94
Scheithauer, W., Kornek, G. V., Marczell, A. P., Karner, J., Salem, G., Greiner, R., Bürger, D., Stöger, F. X., Ritschel, J., Kovats, E., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.225 · Cited by 93
Ding, D., Wang, J., Salvi, R., Henderson, D., Hu, B., McFadden, S. L., & MUELLER, M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08640.x · Cited by 91
Power, J., Mayer-Pröschel, M., Smith, J., & Noble, M. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0610 · Cited by 88
Self-citationKreukels, B. P. C., Schagen, S. B., Ridderinkhof, K. R., Boogerd, W. J., Hamburger, H., & van Dam, F. S. A. M. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-7093-3 · Cited by 86
Cognitive functioning in cancer patients: Effect of previous treatment
Meyers, C. A., & Abbruzzese, J. L. (1992) · Neurology · doi:10.1212/wnl.42.2.434 · Cited by 85
Diffusion-Weighted MRI Correlates of Subacute Methotrexate-Related Neurotoxicity
Haykin, M., Gorman, M., van Hoff, J., Fulbright, R. K., & Baehring, J. M. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-4569-2 · Cited by 82
Stemmer, S. M., Stears, J. C., Burton, B. S., Jones, R. B., & Simon, J. H. (1994) · PubMed Central · Cited by 82
Fransson, P., & Widmark, A. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<678::aid-cncr18>3.0.co;2-e · Cited by 79
5-Fluorouracil-induced leukoencephalopathy in patients with breast cancer
Choi, S. M., Lee, S., Yang, Y. S., Kim, B. C., Kim, M. K., & Cho, K. H. (2001) · Journal of Korean Medical Science · doi:10.3346/jkms.2001.16.3.328 · Cited by 76
Self-citationTreatment of Advanced Pancreatic Cancer
Ducreux, M. P., Boige, V., & Malka, D. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.01.006 · Cited by 73
Shuper, A., Stark, B., Kornreich, L., Cohen, I. J., Aviner, S., Steinmetz, A., Stein, J., Goshen, Y., & Yaniv, I. (2000) · Journal of Child Neurology · doi:10.1177/088307380001500902 · Cited by 72
Prospective intellectual testing in children with brain tumors
Duffner, P. K., Cohen, M. E., & Parker, M. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230608 · Cited by 71
Hackshaw, A. K., Knight, A., Barrett-Lee, P. J., & Leonard, R. C. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602858 · Cited by 67
Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
Shuper, A., Stark, B., Kornreich, L., Cohen, I. J., Avrahami, G., & Yaniv, I. (2002) · PubMed · Cited by 66
Neurological complications of antineoplastic therapy.
Shapiro, W. R., & Young, D. F. (1984) · PubMed · Cited by 64
Current status and future prospects of chemotherapy for metastatic gastric cancer: a review
Ohtsu, A. (2005) · Gastric Cancer · doi:10.1007/s10120-005-0324-9 · Cited by 64
Systemic treatment of gastric cancer
Dickson, J., & Cunningham, D. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200403000-00003 · Cited by 63
Ichikawa, W. (2006) · Gastric Cancer · doi:10.1007/s10120-006-0373-8 · Cited by 63
Neurotoxicity of Cancer Chemotherapy
Dropcho, E. J. (2004) · Seminars in Neurology · doi:10.1055/s-2004-861536 · Cited by 59
Mignone, R. G., & Weber, E. T. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.093 · Cited by 58
Longley, D. B., Allen, W. L., McDermott, U., Wilson, T. R., Latif, T., Boyer, J. D., Lynch, M., & Johnston, P. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0532 · Cited by 57
Cerebral Demyelination with 5-Fluorouracil and Levamisole
Fassas, A., Gattani, A. M., & Morgello, S. (1994) · Cancer Investigation · doi:10.3109/07357909409038226 · Cited by 57
Akiba, T., Okeda, R., & Tajima, T. (1996) · Acta Neuropathologica · doi:10.1007/s004010050482 · Cited by 54
Levamisole-Induced Multifocal Inflammatory Leukoencephalopathy
Wu, V., Huang, J., Lien, H., Hsieh, S., Liu, H., Yang, C., Lin, Y., Hwang, J., & Wu, K. (2006) · Medicine · doi:10.1097/01.md.0000230250.95281.60 · Cited by 54
McDermott, B. J., van den Berg, H. W., & Murphy, R. F. (1982) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00257748 · Cited by 53
Khanna, A., Walker, G. R., Livingstone, A. S., Arheart, K. L., Rocha‐Lima, C., & Koniaris, L. G. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2005.11.006 · Cited by 51
In vivo analysis of oligodendrocyte lineage development in postnatal FGF2 null mice
Murtie, J. C., Zhou, Y., Le, T. Q., & Armstrong, R. C. (2005) · Glia · doi:10.1002/glia.20142 · Cited by 51
Valero, V., Buzdar, A. U., McNeese, M. D., Singletary, E. S., & Hortobágyi, G. N. (2002) · Clinical Breast Cancer · doi:10.3816/cbc.2002.s.014 · Cited by 51
CT abnormalities and altered methotrexate clearance in children with CNS leukemia
Duffner, P. K., Cohen, M. E., Brecher, M. L., Berger, P., Parthasarathy, K. L., Bakshi, S. P., Ettinger, L. J., & Freeman, A. I. (1984) · Neurology · doi:10.1212/wnl.34.2.229 · Cited by 51
Clinical overview: adjuvant therapy of gastrointestinal cancer
Macdonald, J. S. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0880-4 · Cited by 50
Castellon, S. A., Silverman, D. H. S., & Ganz, P. A. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-5342-0 · Cited by 49
Neuroradiology case of the day. Burkitt lymphoma.
Morriss, M. C., & Friedman, D. P. (1998) · Radiographics · doi:10.1148/radiographics.18.5.9747625 · Cited by 49
Dosage Regimen Design for Pharmaceutical Studies Conducted in Animals
Mordenti, J. J. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600750906 · Cited by 48
Cisplatin-induced non-convulsive encephalopathy
Lyass, O., Lossos, A., Hubert, A., Gips, M., & Peretz, T. (1998) · Anti-Cancer Drugs · doi:10.1097/00001813-199801000-00013 · Cited by 47
Intracarotid BCNU leukoencephalopathy
Kleinschmidt-DeMasters, B. K. (1986) · Cancer · Cited by 47
Neurologic complications of chemotherapy for children with cancer
Reddy, A. T., & Witek, K. (2003) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-003-0065-2 · Cited by 46
Voorhess, M. L., Brecher, M. L., Glicksman, A. S., Jones, B., Harris, M., Krischer, J. P., Boyett, J. M., Forman, E. N., & Freeman, A. I. (1986) · Cancer · doi:10.1002/1097-0142(19860401)57:7<1324::aid-cncr2820570712>3.0.co;2-a · Cited by 45
Tha, K. K., Terae, S., Sugiura, M., Nishioka, T., Oka, M., Kudoh, K., Kaneko, K., & Miyasaka, K. (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2002.01253.x · Cited by 45
Phase II Study of Low-Dose Docetaxel/Fluorouracil/Cisplatin in Metastatic Gastric Carcinoma
Park, S. R., Chun, J. H., Kim, Y., Lee, J. H., Choi, I. J., Kim, C. G., Lee, J. S., Bae, J.-M., & Kim, H. K. (2005) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000162424.69631.79 · Cited by 44
Fournier, E., Passirani, C., Montero‐Menei, C. N., Colin, N., Breton, P., Sagodira, S., Meneï, P., & Benoît, J. (2003) · Cancer · doi:10.1002/cncr.11388 · Cited by 43
Savarese, D. M. F., Gordon, J., Smith, T. W., Litofsky, N. S., Licho, R., Ragland, R. L., & Recht, L. D. (1996) · Cancer · Cited by 41
Kimmel, D. W., & Schutt, A. J. (1993) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60132-3 · Cited by 40
Moore, D. H., Fowler, W. C., & Crumpler, L. S. (1990) · Gynecologic Oncology · doi:10.1016/0090-8258(90)90127-7 · Cited by 39
Choi, E. A., Lei, H., Maron, D. J., Mick, R., Barsoum, J., Yu, Q., Fraker, D. L., Wilson, J. M., & Spitz, F. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0040-03 · Cited by 38
Wong, D. K., & Dorovini‐Zis, K. (1996) · Brain Research · doi:10.1016/0006-8993(96)00673-7 · Cited by 37
Luppi, G., Zoboli, A., Barbieri, F., Crisi, G., Piccinini, L., & Silingardi, V. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010610 · Cited by 37
Park, J. K., Ryu, J. K., Lee, J. K., Yoon, W. J., Lee, S. H., Kim, Y., & Yoon, Y. B. (2006) · Pancreas · doi:10.1097/01.mpa.0000236725.26672.be · Cited by 34
Prospects for neuroprotection in multiple sclerosis
Yong, V. W. (2004) · Frontiers in bioscience · doi:10.2741/1276 · Cited by 34
Multifocal Inflammatory Leukoencephalopathy Associated with Levamisole and 5-Fluorouracil
Chen, T. C., Hinton, D. R., Leichman, L., Atkinson, R., Apuzzo, M. L. J., & Couldwell, W. T. (1994) · Neurosurgery · doi:10.1227/00006123-199412000-00019 · Cited by 34
Roncagliolo, M., Benítez, J., & Eguibar, J. R. (2000) · Audiology and Neurotology · doi:10.1159/000013891 · Cited by 32
Neurological complications of 5-fluorouracil chemotherapy: Case report and review of the literature
Bygrave, H. A., Geh, J. I., Jani, Y., & Glynne‐Jones, R. (1998) · Clinical Oncology · doi:10.1016/s0936-6555(98)80093-9 · Cited by 32
Systematic bias in an ?unbiased? neuronal counting technique
von Bartheld, C. S. (1999) · The Anatomical Record · doi:10.1002/(sici)1097-0185(19990815)257:4<119::aid-ar2>3.0.co;2-8 · Cited by 31
Brainstem auditory evoked potential responses in iron-deficient anemic children.
Shankar, N., Tandon, O. P., Bandhu, R., Madan, N., & Gomber, S. (2000) · PubMed · Cited by 31
Cossaart, N., SantaCruz, K. S., Preston, D., Johnson, P., & SKIKNE, B. S. (2003) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703768 · Cited by 30
Abnormal Auditory Brainstem Response Among Infants With Prenatal Cocaine Exposure
Tan-Laxa, M. A., Sison, C. G., Rintelman, W., & Ostrea, E. M. (2004) · PEDIATRICS · doi:10.1542/peds.113.2.357 · Cited by 30
Yamada, M., Nakagawa, H., Fukushima, M., Shimizu, K., Hayakawa, T., & Ikenaka, K. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005869226496 · Cited by 29
Chemotherapy for Breast Cancer Brain Metastases
Fenner, M. H., & Possinger, K. (2002) · Oncology Research and Treatment · doi:10.1159/000067443 · Cited by 27
Chow, L. W. C., & Loo, W. T. Y. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1024995202135 · Cited by 26
Figueredo, A. T., Fawcet, S. E., Molloy, D. W., Dobranowski, J., & Paulseth, J. E. (1995) · Cancer Investigation · doi:10.3109/07357909509024930 · Cited by 26
Auditory brainstem response in children with iron deficiency anemia.
Çankaya, H., Öner, A. F., Egeli, E., Çaksen, H., Üner, A., & Akçay, G. (2003) · PubMed · Cited by 26
Restoration of Brain Stem Auditory-Evoked Potentials by Gene Transfer in Shiverer Mice
Fujiyoshi, T., Hood, L., & Yoo, T. J. (1994) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348949410300606 · Cited by 26
Diffusion-weighted MR imaging of Carmofur-induced leukoencephalopathy
Fujikawa, A., Tsuchiya, K., Katase, S., Kurosaki, Y., & Hachiya, J. (2001) · European Radiology · doi:10.1007/s003300100955 · Cited by 25
Akbulut, H., Tang, Y., Maynard, J., Zhang, L., Pizzorno, G., & Deisseroth, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0490 · Cited by 25
Multifocal Demyelinative Leukoencephalopathy Associated with 5-Fluorouracil and Levamisole
Israel, A. L. Z. H. (2000) · Acta Oncologica · doi:10.1080/028418600431085 · Cited by 24
Bleeker, W. A., Mulder, N. H., Hermans, J., Otter, R., & Plukker, J. T. M. (2000) · Annals of Oncology · doi:10.1023/a:1008351312879 · Cited by 24
A Case of Neurotoxicity Following 5 - Fluorouracil - based Chemotherapy
Ki, S. S., Jeong, J. M., Kim, S. H., Jeong, S., Lee, J. H., Han, C. J., Kim, Y. C., Lee, J. O., & Hong, Y. J. (2002) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2002.17.1.73 · Cited by 24
Ito, T., Tokuriki, M., Shibamori, Y., Saito, T., & Nojyo, Y. (2004) · Hearing Research · doi:10.1016/j.heares.2003.12.019 · Cited by 23
Nakagawa, H., Yamada, M., Fukushima, M., & Ikenaka, K. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050891 · Cited by 22
Leukoencephalopathy induced by chemotherapy with tegafur, a 5-fluorouracil derivative
Ohara, S., Hayashi, R., Hata, S., Itoh, N., Hanyu, N., & Yamamoto, K. (1998) · Acta Neuropathologica · doi:10.1007/s004010050929 · Cited by 21
Murray, C., Ford, W. J., Swenson, K. K., Heros, D. O., & Sperduto, P. W. (1997) · PubMed Central · Cited by 20
Therapeutic efficacy study of novel 5-FU-loaded PMM 2.1.2-based microspheres on C6 glioma
Fournier, E., Passirani, C., Vonarbourg, A., Lemaire, L. P., Colin, N., Sagodira, S., Meneï, P., & Benoît, J. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.08.014 · Cited by 19
The phosphoinositide/protein kinase C system as a potential target for neurotoxicity
Costa, L. G. (1990) · Pharmacological Research · doi:10.1016/1043-6618(90)90747-2 · Cited by 19
Assessing treatment effects on axonal loss?evidence from MRI monitored clinical trials
Barkhof, F. (2004) · Journal of Neurology · doi:10.1007/s00415-004-1403-2 · Cited by 19
Arnold, D. L. (2005) · Journal of Neurology · doi:10.1007/s00415-005-5005-4 · Cited by 17
Heim, W. J., Wampler, G. L., Lokich, J., Brereton, H. D., Scialla, S. J., LaLuna, F. J., Ahlgren, J. D., Nevin, J., Fryer, J. G., & Alt, D. E. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.12.2162 · Cited by 16
Leukoencephalopathy after cisplatin therapy.
Brück, W., Heise, E., & Rl, F. (1990) · PubMed · Cited by 15
5-FU-induced Acute Leukoencephalopathy
Ishibashi, S., Nishimura, H., & Mizusawa, H. (2004) · Internal Medicine · doi:10.2169/internalmedicine.43.1009 · Cited by 15
Central nervous system effects of high-dose cytosine arabinoside.
Herzig, R. H., Herzig, G. P., Wolff, S. N., Hines, J., Fay, J. W., & Phillips, G. L. (1987) · PubMed · Cited by 15
Auditory Brain Stem Response in Neuropathological Mutant Mice (Shiverer and Reeler)
Kanzaki, J., Mikoshiba, K., & Tsukada, Y. (2010) · ORL · doi:10.1159/000275788 · Cited by 14
Reversible Impairment of Auditory Callosal Pathway in 5-Fluorouracil-Induced Leukoencephalopathy
Fujimoto, C., Ito, K. R., Iwasaki, S., Nakao, K., & Sugasawa, M. (2006) · Otology & Neurotology · doi:10.1097/01.mao.0000194815.15298.8b · Cited by 14
Yoshizawa, H., Tanaka, J., Kagamu, H., Maruyama, Y., Miyao, H., Ito, K., Sato, T., Iwashima, A., Suzuki, E., & Gejyo, F. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601227 · Cited by 13
Okusaka, T., Ishii, H., Funakoshi, A., Ueno, H., Furuse, J., & Sumii, T. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyl067 · Cited by 13
Matsumoto, S., Igishi, T., Hashimoto, K., Kodani, M., Shigeoka, Y., Nakanishi, H., Touge, H., Kurai, J., Makino, H., Takeda, K., et al. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.5.1311 · Cited by 13
Hopewell, J. W., & Withers, H. R. (1998) · Medical Physics · doi:10.1118/1.598455 · Cited by 13
5-Fluorouracil- and Levamisole-Associated Multifocal Leukoencephalopathy
Galassi, G., Tassone, G., Sintini, M., Spagnoli, M., Bertolani, L., & Mavilla, L. (2008) · European Neurology · doi:10.1159/000117263 · Cited by 13
Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancer
Ohnoa, S., Toi, M., Kuroi, K., Nakamura, S., Iwata, H., Kusama, M., Masuda, N., Yamazaki, K., Hisamatsu, K., Sato, Y., et al. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(05)80063-0 · Cited by 12
The role of chemotherapy in patients with established gastric cancer
Wagner, D., Schneider, P. M., & Fleig, W. E. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2006.01.002 · Cited by 12
The Cochleovestibular System/Ototoxicity/Clinical Issues
Shulman, A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08660.x · Cited by 12
Critchley, P., Abbott, R., & Madden, F. J. F. (1994) · Clinical Oncology · doi:10.1016/s0936-6555(05)80195-5 · Cited by 12
Paludetti, G., Ottaviani, F., Almadori, G., Cagini, C., Pierri, F., & Maurizi, M. (1987) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/0165-5876(87)90010-3 · Cited by 11
Multifocal Inflammatory Leukoencephalopathy: Use of Thallium-201 SPECT and Proton MRS
Hwang, Y., Suh, C. K., & Park, S. P. (2003) · Journal of Korean Medical Science · doi:10.3346/jkms.2003.18.4.621 · Cited by 11
Monro, A. M., & Mordenti, J. J. (1995) · Toxicologic Pathology · doi:10.1177/019262339502300213 · Cited by 11
Cho, K., Choi, S., Kim, B. C., Lee, S., Park, M., Kim, M., & Kim, J. (2004) · Cancer · doi:10.1002/cncr.20114 · Cited by 10
Atypical hearing loss in women with breast cancer receiving adjuvant treatment
Jenkins, V. A., Beveridge, H., Low, R., & Mitra, S. S. (2005) · The Breast · doi:10.1016/j.breast.2005.06.005 · Cited by 10
Research works printed but not linked: 3
- Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, Waddell K, Petersen L, Phelps ME, Ganz PA: Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Res Treat. 2007, 103: 303-311. 10.1007/s10549-006-9380-z. · DOI · Paper page
- Raimondi AJ, Tomita T: Advantages of 'total' resection of medulloblastoma and disadvantages of full head postoperative radiation therapy. Childs Brain. 1979, 5: 550-551.
- Cankaya H, Oner AF, Egeli E, Caksen H, Uner A, Akcay G: Auditory brainstem response in children with iron deficiency anemia. Acta Paediatr Taiwan. 2003, 44: 21-24.
Cited by
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70294-1 · Cited by 998
Prevalence, mechanisms, and management of cancer-related cognitive impairment
Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864260 · Cited by 745
Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21258 · Cited by 532
Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer
Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A. (2010) · Cancer · doi:10.1002/cncr.25098 · Cited by 513
Oxidative Stress and Neurodegenerative Disorders
Li, J., O, W., Li, W., Jiang, Z.-G., & Ghanbari, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141224438 · Cited by 504
Metadata
- Authors
- Han, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Pröschel, M., & Noble, M.
- Affiliations
- University of Rochester Medicine (US)
- Corresponding author
- Noble, Mark
- Venue
- Journal of Biology
- Published
- 2008-04-22
- Volume
- 7
- Issue
- 4
- Pages
- 12-12
- ISSN
- 1475-4924 (ISSN-L)
- PMC
- PMC2397490
- OpenAlex
- W2152709121
- Cited by
- 316
- References
- 203
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 8 · 2023: 10 · 2022: 21 · 2021: 22 · 2020: 20 · 2019: 16 · 2018: 17 · 2017: 14 · 2016: 25 · 2015: 16 · 2014: 26 · 2013: 25 · 2012: 18
- FWCI
- 18.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Journal of Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institute on Deafness and Other Communication Disorders (R01DC003086)
- National Institute of Neurological Disorders and Stroke (R01NS044701, NS44701)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD39702, R01HD039702)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- 5-fluorouracil, chemotherapy-induced neurotoxicity, white matter degeneration, myelin pathology, transcriptional regulation, auditory system, central nervous system
- MeSH terms
- Action Potentials, Animals, Antineoplastic Agents, Auditory Pathways, Bromodeoxyuridine, Central Nervous System, Fluorouracil, Humans, Indoles, Microscopy, Fluorescence, Myelin Sheath, Stem Cells, Tetrazolium Salts, Thiazoles, In Situ Nick-End Labeling, Cell Line, Tumor, Microscopy, Electron, Transmission, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.